Various pharmaceutical products for systemic use

Finnish Institute for Health and Welfare

Finnish Institute for Health and Welfare, later referred to as THL or Customer, request your tender for "Various pharmaceutical products for systemic use" to the rescEU Medical -project. The Scope of procurement is described in more detail in Annex 1. The procurement is divided in three (3) lots. Each product constitutes a separate lot. Tender may be submitted for one or several lots. LOT 1: Ephedrine hydrochlorid 3 mg/ml (10 ml, i.v. solution, ATC C01CA26) LOT 2: Rocuronium bromid 10 mg/ml (5 ml, i.v. solution, ATC M03AC09) LOT 3: Claritromycin oral suspension 50 mg/ml (50 ml, oral suspension ATC J01FA09) The minimum requirements for the products are described in Annex 1.1. The Contract will be awarded to one Supplier for each lot based on a comparison of tenders. Tender that is economically the most advantageous will win the competition. The contract period shall enter into force once the Contract has been signed by contracting parties and expires when all contractual duties of the Contract have been performed. Quantity for the products is described in Annex 7 (restricted to security classification level IV, TL IV). In addition to the quantity indicated in the Annex 7, the Customer is entitled to purchase 100 % extra to the quantities (later referred as "Option"). The Supplier is not obliged to deliver the products under the Option. Please note that all times given in the Call for tenders refer to local time in Finland. Call for tenders, Annexes: Annex 1 Scope of the procurement Annex 1.1 Minimum requirements Annex 2 Description of the rotation Annex 2.1 Quality scoring table Annex 3 Contract Annex 4 Security annex Annex 5 JYSE 2014 SUPPLIES (updated version of April 2022) Annex 6 Confidentiality commitment Annex 7 Quantity of the Articles (restricted, TL IV) Please note that the numbering of the annexes differs between the Contract and the Call for tenders. The numbering of the Annexes to the Contract is based on the order of precedence applied in the Contract.

Määräaika

Tarjousten vastaanottamisen määräaika oli 2025-03-20. Hankinta julkaistiin 2025-02-14.

Kuka?

• Finnish Institute for Health and Welfare

Mitä?

Missä?

• Helsinki-Uusimaa › Helsinki-Uusimaa

Hankintojen historia

Päivämäärä	Asiakirja
2025-02-14	hankintailmoitus

hankintailmoitus (2025-02-14)
Kohde
Hankinnan laajuus
Otsikko: Various pharmaceutical products for systemic use
Viitenumero: THL/278/2.02.06/2025
Lyhyt kuvaus:

Lyhyt kuvaus

Finnish Institute for Health and Welfare, later referred to as THL or Customer, request your tender for "Various pharmaceutical products for systemic use" to the rescEU Medical -project. The Scope of procurement is described in more detail in Annex 1.

The procurement is divided in three (3) lots. Each product constitutes a separate lot. Tender may be submitted for one or several lots.

LOT 1: Ephedrine hydrochlorid 3 mg/ml (10 ml, i.v. solution, ATC C01CA26)
LOT 2: Rocuronium bromid 10 mg/ml (5 ml, i.v. solution, ATC M03AC09)
LOT 3: Claritromycin oral suspension 50 mg/ml (50 ml, oral suspension ATC J01FA09)

The minimum requirements for the products are described in Annex 1.1.

The Contract will be awarded to one Supplier for each lot based on a comparison of tenders. Tender that is economically the most advantageous will win the competition.

The contract period shall enter into force once the Contract has been signed by contracting parties and expires when all contractual duties of the Contract have been performed.

Quantity for the products is described in Annex 7 (restricted to security classification level IV, TL IV). In addition to the quantity indicated in the Annex 7, the Customer is entitled to purchase 100 % extra to the quantities (later referred as "Option"). The Supplier is not obliged to deliver the products under the Option.

Please note that all times given in the Call for tenders refer to local time in Finland.

Call for tenders, Annexes:

Annex 1 Scope of the procurement
Annex 1.1 Minimum requirements
Annex 2 Description of the rotation
Annex 2.1 Quality scoring table
Annex 3 Contract
Annex 4 Security annex
Annex 5 JYSE 2014 SUPPLIES (updated version of April 2022)
Annex 6 Confidentiality commitment
Annex 7 Quantity of the Articles (restricted, TL IV)

Please note that the numbering of the annexes differs between the Contract and the Call for tenders. The numbering of the Annexes to the Contract is based on the order of precedence applied in the Contract.

Sopimustyyppi: Tavarat
Tuotteet/palvelut: Farmaseuttiset tuotteet 📦
Suorituspaikkaa koskevat rajoitukset: Missä tahansa tietyn maan alueella
Tietoa eristä
Tämä sopimus on jaettu osiin ✅
Yhdelle tarjoajalle myönnettävien erien enimmäismäärä: 3
Tarjouksia voidaan jättää enintään yhtä erää varten: 3

1️⃣
Sisäinen tunniste: 1
Otsikko: LOT 1: Ephedrine hydrochlorid 3 mg/ml (10 ml, i.v. solution, ATC C01CA26)
Tämä hankinta soveltuu myös pienille ja keskisuurille yrityksille (pk-yrityksille) ✅
Hankinnan kuvaus:

The subject of the procurement is Article in accordance with the following requirements: - The subject of tender: Ephedrine hydrochlorid 3 mg/ml (10 ml, i.v. solution, ATC C01CA26) - Parenteral products (intravenous administration) - Active pharmaceutical ingredient: Ephedrine hydrochlorid - Strength: 3 mg/ml - Pharmaceutical form: 10 ml, i.v. solution, vial/ampoule The minimum requirements of the Article is described in more detail in Annex 1.1. The delivery schedule for the articles is described in Annex 1. Quantity for the Article is described in Annex 7 (restricted, TL IV). In addition to the quantity of the Articles indicated in the Annex 7, the Customer shall be entitled to purchase 100 % extra to the original quantities (later referred as "Option") described in the Annex 7. The decision to exercise the Option is in the Customer´s sole discretion. Customer should exercise the Option in part or in whole. The Customer shall notify the Supplier at the latest by the end of June 2026 if it wishes to take on the Option. The delivery schedule for the Option shall be agreed separately between the Contracting Parties. Nevertheless, the Supplier shall not be obliged to agree to deliver the Option to the Customer. The tender shall consist of one (1) Article. The Contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition.

Lisätietoja:

The availability for the Annex 7 is restricted to security classification level IV (TL IV). THL will send the Annex 7 to a representative of the tenderer via encrypted email after THL has received a scanned version of the signed Confidentiality commitment (Annex 6). The signature of the Confidentiality commitment shall be done manually by hand. Confidentiality commitment shall be signed by a legal representative of tenderer. Confidentiality commitment shall be sent to the email address kirjaamo@thl.fi with the subject line "CONFIDENTIALITY COMMITMENT - THL/278/2.02.06/2025 / Various pharmaceutical products for systemic use". The message shall contain name of the tenderer and email address to which the Annex 7 is to be sent.

Tuotteet/palvelut: Sydänlääkkeet 📦
Lisätuotteet/palvelut: Farmaseuttiset tuotteet 📦
Maa: Suomi 🇫🇮
Kesto: 14 kuukautta
Tietoa vaihtoehdoista
Vaihtoehdot ✅
Vaihtoehtojen kuvaus:

In addition to the quantity of the Articles indicated in the Annex 7, the Customer shall be entitled to purchase 100 % extra to the original quantities (later referred as "Option") described in the Annex 7. The decision to exercise the Option is in the Customer´s sole discretion. Customer should exercise the Option in part or in whole. The Customer shall notify the Supplier at the latest by the end of June 2026 if it wishes to take on the Option. The delivery schedule for the Option shall be agreed separately between the Contracting Parties. Nevertheless, the Supplier shall not be obliged to agree to deliver the Option to the Customer.

Myöntämisperusteet
Hinta ✅
Hinta (painotus): 50
Laatukriteeri (nimi): Quality 1: Registered shelf life of the Article
Laatukriteeri (painotus): 10
Laatukriteeri (nimi): Quality 2: Delivery time to the Customer’s warehouse
Laatukriteeri (painotus): 15
Laatukriteeri (nimi): Quality 3: Transportation temperature and excursions
Laatukriteeri (painotus): 3
Laatukriteeri (nimi): Quality 4: Marketing authorisation valid in Finland and Finnish language of packaging
Quality 5: Rotation plan for the Article
Laatukriteeri (painotus): 12
Otsikko
Erän tunnistenumero: LOT-0001

2️⃣
Sisäinen tunniste: 2
Otsikko: LOT 2: Rocuronium bromid 10 mg/ml (5 ml, i.v. solution, ATC M03AC09)
Hankinnan kuvaus:

The subject of the procurement is Article in accordance with the following requirements: - The subject of tender: Rocuronium bromid 10 mg/ml (5 ml, i.v. solution, ATC M03AC09) - Parenteral products (intravenous administration) - Active pharmaceutical ingredient: Rocuronium bromid - Strength: 10 mg/ml - Pharmaceutical form: 5 ml, i.v. solution, vial/ampoule The minimum requirements of the Article is described in more detail in Annex 1.1. The delivery schedule for the articles is described in Annex 1. Quantity for the Article is described in Annex 7 (restricted, TL IV). In addition to the quantity of the Articles indicated in the Annex 7, the Customer shall be entitled to purchase 100 % extra to the original quantities (later referred as "Option") described in the Annex 7. The decision to exercise the Option is in the Customer´s sole discretion. Customer should exercise the Option in part or in whole. The Customer shall notify the Supplier at the latest by the end of June 2026 if it wishes to take on the Option. The delivery schedule for the Option shall be agreed separately between the Contracting Parties. Nevertheless, the Supplier shall not be obliged to agree to deliver the Option to the Customer. The tender shall consist of one (1) Article. The Contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition.

Tuotteet/palvelut: Lihasrelaksantit 📦
Otsikko
Erän tunnistenumero: LOT-0002

3️⃣
Sisäinen tunniste: 3
Otsikko: LOT 3: Claritromycin oral suspension 50 mg/ml (50 ml, oral suspension ATC J01FA09)
Hankinnan kuvaus:

The subject of the procurement is Article in accordance with the following requirements: - The subject of tender: Claritromycin oral suspension 50 mg/ml (50 ml, oral suspension ATC J01FA09) - Oral liquid dosage forms - Active pharmaceutical ingredient: Claritromycin - Strength: 50 mg/ml - Pharmaceutical form: 50 ml oral suspension, bottle The minimum requirements of the Article is described in more detail in Annex 1.1. The delivery schedule for the articles is described in Annex 1. Quantity for the Article is described in Annex 7 (restricted, TL IV). In addition to the quantity of the Articles indicated in the Annex 7, the Customer shall be entitled to purchase 100 % extra to the original quantities (later referred as "Option") described in the Annex 7. The decision to exercise the Option is in the Customer´s sole discretion. Customer should exercise the Option in part or in whole. The Customer shall notify the Supplier at the latest by the end of June 2026 if it wishes to take on the Option. The delivery schedule for the Option shall be agreed separately between the Contracting Parties. Nevertheless, the Supplier shall not be obliged to agree to deliver the Option to the Customer. The tender shall consist of one (1) Article. The Contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition.

Tuotteet/palvelut: Systeemiset bakteerilääkkeet 📦
Otsikko
Erän tunnistenumero: LOT-0003

Menettely
Toimenpiteen tyyppi
Avoin menettely ✅
Oikeusperusta: Direktiivi 2014/24/EU
Menettelyn tärkeimmät piirteet:

Tenders must be submitted electronically via the Cloudia Supplier Portal. It is the responsibility of the tenderer to submit the tender by the deadline. No compensation will be paid for submitting a tender. Requirements concerning tenderers and the Article, as well as eventual reports and explanations required in the tender, are described in this Call for tenders. All the attachments mentioned in the Call for tenders should be sent with the tender. The tender must be submitted in writing, in English. Also, the annexes and all related material or correspondence must be in English. The process steps are: 1. Opening the tenders. 2. Inspecting the suitability of tenderers according to the ESPD form. 3. Inspecting that tenders meet the requirements set in the Call for tenders. 4. Comparison of tenders. 5. Making and announcing the Procurement decision. 6. Verifying the information given by the awarded tenderer on the ESPD form. 7. Background check by asking the winning tenderer to submit criminal record exctracts. 8. Drafting the Contract. The Contract is only valid after a written Contract is signed. The Contract can be signed no earlier than 14 days from the time the tenderer has been informed, or is considered to have been informed, of the Procurement decision and its grounds (= stand-still period).

Hallinnolliset tiedot
Tarjousten tai osallistumishakemusten vastaanottamisen määräaika: 2025-03-20 10:00:00 📅
Tarjousten avaamista koskevat ehdot: 2025-03-20 10:30:00 📅
Kielet, joilla tarjoukset tai osallistumishakemukset voidaan jättää: englanti 🗣️
Vähimmäisaika, jonka kuluessa tarjoajan on pidettävä tarjous voimassa: 6 kuukautta
Tarjouspyynnön ehdot
Tarjoaja voi jättää useamman kuin yhden tarjouksen
Tarjousten avaamisen päivämäärä: 2025-03-20 10:30:00 📅
Sähköinen laskutus: Sallittu
Sähköistä maksua käytetään ✅
Lisätietojen pyytämisen määräaika: 2025-03-06 10:00:00 📅
Myöntämisperusteet
Painotustyyppi: Painotus (pisteinä, tarkka)
Tarjouspyynnön ehdot
Sopimukseen sisältyy suoritusehtoja ✅
Salassapitosopimus on pakollinen ✅

Oikeudelliset, taloudelliset, rahoitukselliset ja tekniset tiedot
Taloudellinen ja rahoituksellinen asema
Luettelo ja lyhyt kuvaus valintaperusteista:

Yearly turnover: The tenderer´s financial prerequisites are sufficient with regard to the size and nature of the procurement. In order that the tenderer may be estimated to be able to provide and deliver the Articles subject to procurement, the Customer requires that the tenderer´s turnover each of the two (2) previous accounting years (2022 and 2023) have been at least one million euros (1 000 000 EUR).

Osallistumisehdot
Luettelo ja lyhyt kuvaus olosuhteista:

Enrolment in a trade register: It is enrolled in the relevant trade registers kept in the Member State of its establishment.

Sopimukseen liittyvät ehdot
Sopimuksen täytäntöönpanoehdot: For further details please see the documents of the Call for tenders.
Osallistumisehdot
Poissulkemisperuste:

Ennenaikainen irtisanominen, vahingonkorvaukset tai muut vastaavat seuraamukset

Järjestelyt velkojien kanssa

Kansallisesta lainsäädännöstä johtuva konkurssia tai muuta sellaista vastaava tilanne

+ 20 lisää

Konkurssi

Korruptio

Lapsityövoima ja muut ihmiskaupan muodot

Liiketoiminta on keskeytetty

Maksukyvyttömyys

Petos

Puhtaasti kansalliset poissulkemisperusteet

Rahanpesu tai terrorismin rahoitus

Rikollisjärjestön toimintaan osallistuminen

Sosiaalilainsäädännön mukaisten velvoitteiden rikkominen

Sosiaaliturvamaksujen maksaminen

Syyllistyminen ammatin harjoittamiseen liittyvään vakavaan virheeseen

Talouden toimijan hankintamenettelyyn osallistumisesta johtuvat eturistiriidat

Terrorismirikokset tai terroritoimintaan liittyvät rikokset

Toisten talouden toimijoiden kanssa kilpailun vääristämiseksi tehdyt sopimukset

Työlainsäädännön mukaisten velvoitteiden rikkominen

Varat selvitysmiehen hallinnassa

Verojen maksu

Välitön tai välillinen osallistuminen tämän hankintamenettelyn valmisteluun

Ympäristölainsäädännön mukaisten velvoitteiden rikkominen

Kuvaus poissulkemisperusteista:

The economic operator is in any analogous situation like bankruptcy arising from a similar procedure under national laws and regulations.

The economic operator is bankrupt.

The economic operator itself or any person who is a member of its administrative, management or supervisory body or has powers of representation, decision or control therein has been the subject of a conviction by final judgment for corruption, by a conviction rendered at the most five years ago or in which an exclusion period set out directly in the conviction continues to be applicable.

The economic operator is in arrangement with creditors.

The economic operator itself or any person who is a member of its administrative, management or supervisory body or has powers of representation, decision or control therein has been the subject of a conviction by final judgment for participation in a criminal organisation, by a conviction rendered at the most five years ago or in which an exclusion period set out directly in the conviction continues to be applicable.

The economic operator has entered into agreements with other economic operators aimed at distorting competition.

The economic operator has breached its obligations in the field of environmental law.

… money laundering or terrorist financing, by a conviction rendered at the most five years ago or in which an exclusion period set out directly in the conviction continues to be applicable.

… fraud, by a conviction rendered at the most five years ago or in which an exclusion period set out directly in the conviction continues to be applicable.

… child labour and other forms of trafficking in human beings, by a conviction rendered at the most five years ago or in which an exclusion period set out directly in the conviction continues to be applicable.

The economic operator is the subject of insolvency or winding-up.

The economic operator has breached its obligations in the field of labour law.

The assets of the economic operator are being administered by a liquidator or by the court.

Any person who is a member of the economic operator’s administrative, management or supervisory body or has powers of representation, decision or control therein has been the subject of a conviction by final judgment for work safety offence, working hours offence, work discrimination, extortionate work discrimination, violation of the right to organise or unauthorised use of foreign labour.

The economic operator is aware of any conflict of interest, as indicated in national law, the relevant notice or the procurement documents due to its participation in the procurement procedure.

The economic operator or an undertaking related to it has advised the contracting authority or contracting entity or otherwise been involved in the preparation of the procurement procedure.

The economic operator is guilty of grave professional misconduct.

The economic operator has experienced that a prior public contract, a prior contract with a contracting entity or a prior concession contract was terminated early, or that damages or other comparable sanctions were imposed in connection with that prior contract.

The economic operator has breached its obligations in the field of social law.

The economic operator has breached its obligations relating to the payment social security contributions, both in the country in which it is established and in Member State of the contracting authority or contracting entity if other than the country of establishment.

The business activities of the economic operator are suspended.

The economic operator has breached its obligations relating to the payment of taxes, both in the country in which it is established and in Member State of the contracting authority or contracting entity if other than the country of establishment.

The economic operator itself or any person who is a member of its administrative, management or supervisory body or has powers of representation, decision or control therein has been the subject of a conviction by final judgment for terrorist offences or offences linked to terrorist activities, by a conviction rendered at the most five years ago or in which an exclusion period set out directly in the conviction continues to be applicable.

Hankintaviranomainen
Nimi ja osoitteet
Nimi: Finnish Institute for Health and Welfare
Kansallinen rekisterinumero: 2229500-6
Postiosoite: P. O. BOX 30
Postinumero: 00271
Postitoimipaikka: Helsinki
Alue: Helsinki-Uusimaa 🏙️
Maa: Suomi 🇫🇮
Yhteyspiste: Procurement services / Keskitetty hankintatoimi
Sähköposti: kilpailutus@thl.fi 📧
Puhelin: +358 295246000 📞
URL: https://thl.fi/en/web/thlfi-en 🌏
Hankintaviranomaisen tyyppi
Ministeriö tai muu kansallinen tai liittovaltiotason viranomainen
Päätoimi
Terveys
Viestintä
Osallistumisen URL-osoite: https://tarjouspalvelu.fi/thl?id=547371&tpk=0985e5b0-86e7-45b2-abee-e45f7eb4fedb 🌏
EU:n rahoituksen tunniste: rescEU-MED-CBRN-FI
Lisätietoa EU-rahoituksesta: rescEU - Medical Stockpiling in Finland
EU:n rahoitusohjelma: Unionin pelastuspalvelumekanismi (rescEU) (2021/2027)
Perustelut tiettyjen hankinta-asiakirjojen saatavuuden rajoittamiselle: Erityisen arkaluonteisten tietojen suojaaminen
Hankinta-asiakirjoihin pääsyä on rajoitettu
Tarjouksen/hakemuksen jättäminen sähköisesti: Pakollinen

Täydentävät tiedot
Lisätietoja

Arvostelurunko
Nimi: Markkinaoikeus
Kansallinen rekisterinumero: 3006157-6
Postiosoite: Radanrakentajantie 5
Postinumero: 00520
Postitoimipaikka: Helsinki
Alue: Helsinki-Uusimaa 🏙️
Maa: Suomi 🇫🇮
Sähköposti: markkinaoikeus@oikeus.fi 📧
Puhelin: +358 295643300 📞
URL: http://www.oikeus.fi/markkinaoikeus 🌏
Tietoa sähköisistä työnkuluista
Sähköinen laskutus hyväksytään
Lähde: OJS 2025/S 033-104047 (2025-02-14)

Uudet hankinnat asiaan liittyvissä luokissa 🆕

Lääketieteelliset laitteet, farmaseuttiset valmisteet ja henkilökohtaiseen hygieniaan liittyvät tuotteet (>20 uudet hankinnat)

Farmaseuttiset tuotteet (8)